Ausdal Financial Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,683
Closed -$409K 486
2021
Q4
$409K Sell
6,683
-2,294
-26% -$140K 0.05% 319
2021
Q3
$671K Sell
8,977
-19,658
-69% -$1.47M 0.1% 229
2021
Q2
$2.65M Buy
28,635
+10,669
+59% +$987K 0.4% 76
2021
Q1
$1.59M Sell
17,966
-13,274
-42% -$1.18M 0.27% 111
2020
Q4
$2.91M Buy
31,240
+27,321
+697% +$2.55M 0.57% 49
2020
Q3
$250K Buy
+3,919
New +$250K 0.06% 292